George W. Muller
174Patents
37h-index
42Co-inventors
90Inventor score
Filing activity: Oct 2, 1987 → Sep 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5635517A | Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines | Emerging Cross-Sectional Technologies | 275 | Expired |
| US5698579A | Cyclic amides | Chemistry; Metallurgy | 172 | Expired |
| US5877200A | Cyclic amides | Chemistry; Metallurgy | 170 | Expired |
| US6281230A | Isoindolines, method of use, and pharmaceutical compositions | Human Necessities | 161 | Expired |
| US6316471A | Isoindolines, method of use, and pharmaceutical compositions | Human Necessities | 159 | Expired |
| US5929117A | Immunotherapeutic agents | Chemistry; Metallurgy | 154 | Expired |
| US5798368A | Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNF.alpha. levels | Chemistry; Metallurgy | 153 | Expired |
| US6458810B1 | Pharmaceutically active isoindoline derivatives | Chemistry; Metallurgy | 150 | Expired |
| US6476052B1 | Isoindolines, method of use, and pharmaceutical compositions | Human Necessities | 149 | Expired |
| US6335349B1 | Substituted 2(2,6-dioxopiperidin-3-yl)isoindolines | Human Necessities | 142 | Expired |
| US5955476A | Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels | Human Necessities | 142 | Expired |
| US6020358A | Substituted phenethylsulfones and method of reducing TNF.alpha. levels | Emerging Cross-Sectional Technologies | 136 | Expired |
| US5874448A | Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNF.alpha. levels | Chemistry; Metallurgy | 136 | Expired |
| US6555554B2 | Isoindolines, method of use, and pharmaceutical compositions | Emerging Cross-Sectional Technologies | 133 | Expired |
| US6403613B1 | 1-oxo-and 1,3-dioxoisoindolines | Emerging Cross-Sectional Technologies | 131 | Expired |
| US6395754B1 | Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNF&agr; levels | Emerging Cross-Sectional Technologies | 131 | Expired |
| US6380239B1 | Substituted 1-oxo- and 1,3-dioxoisoindoline and method of reducing inflammatory cytokine levels | Human Necessities | 125 | Expired |
| US5728844A | Immunotherapeutic agents | Chemistry; Metallurgy | 107 | Expired |
| US7244759B2 | Isoindoline compounds and methods of making and using the same | Chemistry; Metallurgy | 93 | Expired |
| US7091353B2 | Isoindole-imide compounds, compositions, and uses thereof | Chemistry; Metallurgy | 85 | Expired |
| US6011050A | Substituted phenethylsulfones and method of reducing TNF.alpha. levels | Emerging Cross-Sectional Technologies | 80 | Expired |
| US5605914A | Imides | Chemistry; Metallurgy | 66 | Expired |
| US6326388A | Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level | Emerging Cross-Sectional Technologies | 65 | Expired |
| US5801195A | Immunotherapeutic aryl amides | Emerging Cross-Sectional Technologies | 61 | Expired |
| US5658940A | Succinimide and maleimide cytokine inhibitors | Chemistry; Metallurgy | 61 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.